XM无法为美国居民提供服务。
D
D

DiaSorin

交易方向

交易者偏好

技术摘要

每小时

市场新闻

Adyen NV, Beazley, Nel ASA

EUROPE RESEARCH ROUNDUP-Adyen NV, Beazley, Nel ASA Aug 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adyen NV, Beazley and Nel ASA, on Friday. HIGHLIGHTS * Adyen NV ADYEN.AS : TD Cowen raises target price to EUR 1,620 from EUR 1,618 * Beazley BEZG.L : HSBC raises target price to 780p from 665p * Diageo DGE.L : HSBC cuts target price to 3,000p from 3,300p * Nel ASA NEL.OL : Berenberg cuts to hold from buy * ThyssenKrupp Nucera
A
A
B
B
B
C
C
D
D
E
F
F
G
H
I
L
P
P
S
T
V
D
D
F

Euronext, Pearson, Saint-Gobain

EUROPE RESEARCH ROUNDUP- Euronext, Pearson, Saint-Gobain July 30 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Euronext, Pearson and Saint-Gobain on Tuesday. HIGHLIGHTS * Adyen NV ADYEN.AS : HSBC cuts target price to EUR 1600 from EUR 1900 * Deutsche Boerse AG DB1Gn.DE : JP Morgan raises target price to EUR 198 from EUR 194 * Euronext NV ENX.PA : JP Morgan cuts target price to EUR 107 from EUR 108 * Pearson PSON.L : JP Morgan cut
A
C
C
D
D
E
E
H
H
L
L
P
P
P
R
S
S
S
A
D
J
S

Italy - Factors to watch on July 30

Italy - Factors to watch on July 30 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Chinese President Xi Jinping and Italian Prime Minister Giorgia Meloni discussed the war in Ukraine and the crisis in the Middle East at a meeting in Beijing on Monday, Meloni's office said.
A
B
E
H
I
L
R
A
D
D
F
I
P
I
U

DiaSorin raises 2024 guidance slightly following Q2 results

UPDATE 1-DiaSorin raises 2024 guidance slightly following Q2 results Adds revenue and adj. core profit in paragraph 3-4, shares movement in 5 July 29 (Reuters) - Italian medical diagnostics group DiaSorin DIAS.MI raised its guidance slightly for 2024 after reporting on Monday a 9% rise in second-quarter adjusted core profit. The company said it now expects revenue growth this year of between 6%-7% compared to previous guidance of 5%-7% growth, and sees its 2024 adjusted core profit margin at abo
D

DiaSorin slightly raises 2024 guidance following Q2 results

DiaSorin slightly raises 2024 guidance following Q2 results July 29 (Reuters) - Italian medical diagnostics group DiaSorin DIAS.MI on Monday slightly hiked guidance for 2024, after its second quarter adjusted core profit rose 9% at a constant exchange rate compared to the same period last yea. The company now expects for 2024 a growth in revenue excluding Covid between 6%-7% compared to previous guidance of 5%-7% growth, and sees its 2024 adjusted core profit margin at about 33% compared to a pr
D

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明